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Abstract
Purpose: Computed tomography (CT) and positron emission tomography (PET) are the mainstay imaging methods 
in the evaluation and follow-up of pulmonary nodules. But they both have high radiation risk for patients. Diffusion- 
weighted magnetic resonance imaging (DW-MRI), on the other hand, is a radiation free imaging method that gives 
information about the biological structure of tissues at the molecular level by measuring random movement of water 
in biological tissues. In this prospective study we aimed to compare the computed tomography characteristics of the 
nodules in terms of malignancy and to compare the accuracy of DW-MRI and PET/CT results in those patients.
Material and methods: Seventy-six patients suspicious for lung cancer on thorax CT imaging were prospectively further 
evaluated by thorax diffusion-weighted imaging and PET/CT. Pulmonary lesion characteristics, apparent diffusion 
coefficient (ADC), and maximum standardised uptake values (SUVmax) were compared with histopathological results.
Results: There was statistically significant moderate negative correlation between PET-SUVmax and ADC values of 
lung lesions. ADC values below the cut-off was 97.1%, specificity was 97.6%, positive predictive value was 97.1%, 
and the negative predictive value was 97.6%.
Conclusions: DAG-MRI and PET/CT have similar success in the differentiation of benign and malignant lung lesions.
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Introduction
Pulmonary nodules are common findings in thoracic com-
puted tomography (CT) examinations referred for differ-
ent pulmonary complaints or for further imaging of the 
pulmonary nodules that are visible in chest radiography. 
The malignancy risk of the nodules increases with 
the nodule size. In order to prevent unnecessary surgery, 
the characterisation of the nodule by noninvasive methods 
is fundamental. CT is the main imaging technique applied 
for the evaluation of pulmonary nodules, and it is based 
on morphological assessment of nodules [1]. The morpho-
logical analysis of solitary pulmonary nodules (SPN) in 
CT such as location, size, margin features, shapes, and en-
hancement features are important and are beneficial in the 
benign/malignant differentiation of nodules [2].
However, in some cases it is difficult to differentiate 
malignant lesions and granulomas or some hypervascular 
benign lesions [3]. Besides, the maximum standard fluo-
rodeoxyglucose (FDG) uptake (maximum standardised 
uptake values [SUVmax]) in positron emission tomography 
(PET) shows the metabolic activity of a tumour. High SUV 
values are associated with cell proliferation and poor prog-
nosis in lung tumours [4].
 Evaluation of pulmonary nodules with DW-MRI
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Because of its higher resolution in soft tissue struc-
tures, magnetic resonance imaging (MRI) is preferred in 
the diagnosis and follow-up of many tumours. Conven-
tional MRI techniques are being used in the evaluation of 
solitary pulmonary nodules but occasionally have shown 
controversy in differentiation of benign versus malignant 
nodules [5].
Similarly, dynamic contrast-enhanced MRI showed oc-
casional overlaps in malignant lesions and inflammatory 
lesions. In this respect, various MRI techniques that pro-
vide metabolic and biophysical information, as well as the 
standard sequences, have been increasingly used [6]. 
Diffusion-weighted imaging (DWI) is a noninvasive 
method that gives information about the biological struc-
ture of tissues at the molecular level based on the random 
movement of water in biological tissues. It is quantified as 
the ‘apparent diffusion constant’ (ADC) [7]. The diffusion 
of water in the tissues often varies in several diseases, giv-
ing clues about tissue density or tissue viability [8].
Although DWI is primarily used in cranial imaging, 
DWI use has become applicable in other organs with echo- 
planar MRI techniques [9]. Because of the highly cellular 
structure and high tissue disorganisation of the malignant 
lesions, although the number is limited, various studies 
have been planned in order to evaluate the pulmonary nod-
ules with DWI because the movement of intracellular water 
will be restricted in these cases.
In this prospective study, we aimed to compare the 
characteristics of the nodules in CT examinations in terms 
of benign versus malignant features and to compare the ac-
curacy of diffusion-weighted MRI (DW-MRI) and PET/CT 
results in making this differentiation.
Material and methods
Ethics Committee approval was obtained for our study, 
and written consent was obtained from each patient. 
Between the years of 2014 and 2017, patients who 
underwent thorax CT with a 64-section CT device (Bril-
liance 64, Philips Medical Systems, Best, Netherlands) 
were evaluated. 
CT parameters were as follows: 120 kVp; 120 mAs; 
collimation, 64 × 0.625; pitch, 1.078; rotation time. 0.75 
ms; matrix 521 × 521 pixels. Patients who had increased 
nodule size in follow-up, nodules greater than 1 cm 
with increased density or with irregular borders, ground 
glass nodules larger than 1 cm with solid component in 
thin-section CT slices, and having primary lung cancer 
suspicion underwent further thoracic DWI-MRI (Table 1). 
For the MRI examination, 1.5 Tesla MR Devices (Achie-
va, Philips Medical Systems, Best, Netherlands) were used. 
Patients who had diffusion restriction in DAG and pa-
tients who did not have any diffusion restriction but had 
high risk according to clinician were referred to PET/CT. 
At the end of these procedures the patients who un-
derwent biopsy were included in this study. Biopsies were 
performed transbronchially or percutaneously. Seventy-six 
patients (60 male, 16 female) who underwent biopsy, de-
pending on the test results, were included in the study.
MRI images were performed by a radiologist who had 
five years of experience in thorax imaging. DWI-MRI im-
ages were qualitatively compared to neighbouring muscle 
structures by examining the signal characteristics of the 
lesions in terms of signal intensity. ADC maps were calcu-
lated on a pixel-by-pixel basis using a computer program. 
Round ROI was selected two different measurements were 
performed by placing the circle on the solid section of the 
lesion if existed by leaving the necrotic areas outside and 
the average value is taken.
All 18F-FDG PET-CT examinations were performed 
with a PET/CT device (Gemini TF, Philips Healthcare, Best, 
Netherlands). After at least six hours of fasting, the glucose 
levels of the patients were controlled, and patients with val-
ues lower than 140 mg/dl were given intravenous 2-deoxy- 
2-fluoro-D-glucose (18FDG). CT images were taken 
60 minutes after injection. Patients were then switched to 
PET imaging without changing position, and images were 
taken. CT images were used for the attenuation and correc-
tion of the PET image acquisition (Figure 1).
Statistical analysis
Statistical analysis of data was made with SPSS (Statisti-
cal Package for the Social Sciences) version 15.0. Data of 
continuous variables are given as mean ± standard devia-
tion and median; data of interval and categorical variables 
are given as frequency and percentile. Pearson’s test was 
used for correlations and receiver operating characteris-
tics (ROC) analysis for determining the cut-off values; 
in the analysis of group comparisons, χ2 test, Fischer’s 
exact for categorical variables, and Student’s t-test and 
Mann-Whitney U test for continuous variables were used. 
Results were evaluated with a 95% confidence interval 
and a significance level of p < 0.05 (*p < 0.05, **p < 0.01, 
***p < 0.001).
Table 1. Thoracic diffusion-weighted magnetic resonance imaging acqui-
sition parameters
Imaging parameters
TR/TE (ms) 2600/65
TI (ms) 180
In-plane resolution 4.4 x 5.5 x 5
NSA 3
Matrix 92
FOV 425 x 278
EPI-factor 21
B-values (s/mm2) 0-500
Acquisition time < 120
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Results
Among 76 patients included in the study 78.9% were 
male and 21.1% were female. Patients’ ages ranged from 
36 to 85 years with a mean value of 57.79 ± 10.71 years. 
The male gender ratio and the mean age were higher in 
the malignant patients than the benign ones, without any 
statistically significant difference (p < 0.05).
The pathological diagnosis distribution of the nodules 
is shown in Figure 2.
There were no statistically significant differences be-
tween benign versus malignant pulmonary nodules re-
garding the presence of apical tuberculosis sequelae and 
the presence of bronchiectasis and sequelae in the neigh-
bourhood of the nodule (p > 0.05). The central location 
of the nodule/mass, on the other hand, was seen to be 
significantly higher in malignant lesions (p < 0.05).
Mediastinal and hilar lymphadenopathy (LAP) and 
emphysematous lung parenchyma, especially in the upper 
zones, were found to be significantly higher in malignant 
lesions (p < 0.05). Also, the presence of being an active 
smoker or having quit less than one year before was statis-
tically significantly higher in malignant nodules compared 
to benign nodules (p < 0.05).
Size of nodules and mediastinal and hilar lymphade-
nopathies were statistically significantly larger, PET SUVmax 
A
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Figure 1. Image examples of a 57-year-old patient with small cell carcinoma of the right lower lobe. A) Thorax contrast-enhanced computed tomography 
scan (mediastinal window setting), B) diffusion-weighted magnetic resonance imaging of the tumor with hyperintensity, C) corresponding ADC map 
appearing as a low signal intensity (ADCmin = 0.82 × 10
−3 mm2/s) and D) combined positron emission tomography and computed tomography of the same 
patient with a maximum standardised uptake values of 12.4
Benign 
Epidermoid carcinoma
Lung adenocarcinoma
Other primer lung cancers
Lung metastases 
26.3
52.6
10.5
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Figure 2. Pathological diagnosis of nodules (%)
values of nodule/mass and mediastinal and hilar LAP were 
statistically significantly higher, and minimum, maxi mum, 
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and mean values of ADC of mass/nodule in MR DAG were 
statistically significantly lower in malignant nodules com-
pared to benign nodules (p < 0.05).
There was statistically significant moderate negative 
correlation between PET-SUVmax and minimum, maxi-
mum, and average DAG-ADC values of lung mass/nodule 
and a statistically significant weak negative correlation be-
tween PET-SUVmax and DAG-ADS values of mediastinal 
and hilar lymphadenopathies (p < 0.05) (Table 2).
In ROC analysis of PET SUVmax of lung mass/nodule, 
the area under the curve was 0.962 ± 0.023 (p = 0.0001), 
the cut-off value was 3.75, sensitivity for values above the 
cut-off was 94.1%, specificity was 92.9%, positive predic-
tive value was 91.4%, and the negative predictive value 
was 95% (Figure 3).
In ROC analysis of DAG-ADC min, the area under the 
curve was 0.975 ± 0.018 (p = 0.0001), the cut-off value was 
1.143, sensitivity for values below the cut-off was 97.1%, 
specificity was 97.6%, positive predictive value was 97.1%, 
and the negative predictive value was 97.6% (Figure 4).
Discussion
DAG targets the diffusion status of water molecules in tis-
sue. In any structural change in the ratio of intracellular 
and extracellular water molecules, the diffusion of water 
causes a change in the DAG signal because it will be dis-
rupted by intracellular macromolecules and organelles [10]. 
 The quantitative evaluation of diffusion is possible with 
the calculated ADC value based on the proportion of ex-
tracellular and intracellular components in DAG [11]. 
The ADC value tends to be low in malignant lesions due 
to increased tissue density and cellularity [12]. In addi-
tion, intracellular cytoskeleton, organelles, soluble macro-
molecules, and matrix fibres also affect the diffusion lim-
itation in addition to cell membranes; thus, ADC values 
are expected to be different in different histopathological 
circumstances [13]. 18F-FDG PET/CT evaluates the glu-
cose metabolism in tumours by measuring the adminis-
tered marked form of glucose that is not metabolised and 
therefore accumulates in vital cells. Increased FDG uptake 
reflects the high metabolic activity of the tumour due to 
increased glycosylation in malignant tumours [14]. 
In this prospective study evaluating pulmonary nod-
ules, the incidence of benign lesions was more frequent 
than that of malignant lesions. The findings favouring ma-
lignancy were consistent with the results of other studies 
[15]. However, results in our study favouring central lo-
calisation of the malignant lesions was incompatible with 
some studies in the literature [15, 16]. This difference may 
be due to the limited number of our sample. Emphysema-
tous changes seen in the upper zones in malignant lesions, 
which were significantly more frequent than the patients 
with benign lesions, and higher frequency of malignant 
Table 2. Correlation between PET-SUVmax and DAG-ADC values
DAG-ADC (minimum) DAG-ADC (maximum) DAG-ADC (average)
r p r p r p
PET-SUVmax value of lung mass –0.631 0.0001*** –0.619 0.0001*** –0.616 0.0001***
PET-SUVmax value of mediastinal LAP –0.389 0.001** –0.417 0.0001*** –0.420 0.0001***
PET-SUVmax value of hilar LAP –0.319 0.005** –0.374 0.001** –0.378 0.001**
Figure 3.  ROC analysis of PET SUVmax of lung mass/nodule for the distinction 
of benign and malign nodules 
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Figure 4. ROC analysis of magnetic resonance for the distinction of benign 
and malign nodules  
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lesions in our study in active smokers and smokers up to 
the preceding year, support the relationship of centrilobu-
lar emphysema seen in upper zones with smoking.
The comparison of DAG-ADC and PET-SUV values, 
which was the aim of our study, showed that SUV values 
were significantly higher in malignant lesions and hi-
lar-mediastinal LAPs, while ADC values were shown to be 
significantly lower, consistent with the literature [17-21]. 
In our study, we obtained higher sensitivity, positive pre-
dictive value, and negative predictive values compared to 
Liu et al.’s study, in the differentiation of malignant nod-
ules from benign nodules, below the cut-off value of 1.143 
in the ROC analysis for DAG-ADC min [21]. In a study 
by Regier et al. comparing 41 non-small cell lung can-
cer patients with PET-SUV max values and DAG-ADC 
min values, a strong inverse correlation was found [22]. 
The relationship between SUV and ADC values was also 
found in different studies of different types of cancer, such 
as rectal carcinoma [23] and brain metastasis [24]. When 
the relationship between ADC min and SUV values was 
evaluated we found a moderate correlation between them.
In the ADC evaluation of pulmonary cancer subtypes, 
in Matoba et al.’s study [19] with 30 lung cancer patients, 
the ADC values of adenocarcinomas were higher than val-
ues of squamous cell carcinoma and large cell carcinomas, 
and well-differentiated adenocarcinomas had higher val-
ues that poorly differentiated ones. In other studies [25], 
small cell lung cancers had higher ADC values than ade-
nocarcinoma and squamous cell carcinomas. In our study, 
ADC values of adenocarcinomas had higher ADC values 
than other lung cancer types, as reported in the study by 
Matoba et al.; however, despite the high number of total 
patients in our study, the relatively small number of pa-
tients with malignant nodules was a limitation. One tech-
nical limitation was motion-induced artefacts that caused 
image distortion, which made the evaluation difficult.
Conclusions
Based on this prospective study, we can say that DAG-
MRI has similar success with PET in the differentiation 
of benign versus malignant pulmonary nodules with a di-
ameter greater than 1 cm. Although the sensitivity and 
specificity of the cut-off values we found in our study 
were higher than in similar studies, we think that more 
comprehensive studies should be performed to determine 
a cut-off value and to evaluate the change of ADC values 
among the subtypes of malignant lesions.
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